Loading…

AbbVie agreed to acquire a device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, planning to hire ~200 employees and invest over $175 million to modernize the site.
“AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West.”barchart.com
Summarized from public sources; check the original articles before acting on it.